providing a standardized, easy-to-use, and affordable clinical trial management system, along with the world's first independent networking platform for sponsors, study sites, and investigators. We utilize AI and blockchain to maximize efficiency in clinical trial data analysis.

In the context of the SynapCon business plan, the use of Web3 technology is likely aimed at providing a more efficient and secure platform for clinical trials, with features such as decentralized data storage, secure sharing of patient data, and streamlined communication between different stakeholders in the clinical trial process.